MAKE APPOINTMENT

Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaro

by | Sep 30, 2026 | Uncategorized | 0 comments

A Novo-funded claims analysis tied raising Ozempic to 2 mg with 6% lower heart risk than switching to Mounjaro. Here is why confounding matters.

Submit a Comment

Your email address will not be published. Required fields are marked *